First Korean case of factor V Leiden mutation in pregnant woman with a history of recurrent pregnancy loss |
Han, Sung Hee
(Division of Biotechnology, Bio-Core Co. Ltd.)
Seo, Jung Jae (Department of Obstetrics and Gynecology, Women's I Hospital) Kim, Eun Seol (Department of Obstetrics and Gynecology, Women's I Hospital) Ryu, Jae Song (Division of Biotechnology, Bio-Core Co. Ltd.) Hong, Seong Hyeon (Division of Biotechnology, Bio-Core Co. Ltd.) Hwang, Seung Yong (Division of Biotechnology, Bio-Core Co. Ltd.) |
1 | Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010;93:1234-43. DOI |
2 | Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601-11. DOI |
3 | Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999;82:634-40. DOI |
4 | Younis JS, Ohel G, Brenner B, Ben-Ami M. Familial thrombophilia--the scientific rationale for thrombophylaxis in recurrent pregnancy loss? Hum Reprod 1997;12:1389-90. DOI |
5 | Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994;24:139-51. |
6 | Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4. DOI |
7 | De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998;24:367-79. DOI |
8 | Kim TW, Kim WK, Lee JH, Kim SB, Kim SW, Suh C, et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. J Korean Med Sci 1998;13:587-90. DOI |
9 | Chang JD, Hur M, Lee SS, Yoo JH, Lee KM. Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin Orthop Relat Res 2008;466:1041-6. DOI |
10 | Kim S, Song I, Kim HK, Huh S. Thrombophilia in Korean patients with arterial or venous thromboembolisms. Ann Surg Treat Res 2016;90:340-5. DOI |
11 | Lee GS, Park JC, Rhee JH, Kim JI. Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women. Obstet Gynecol Sci 2016;59:379-87. DOI |
12 | Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997;176:883-6. DOI |
13 | Sergi C, Al Jishi T, Walker M. Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Arch Gynecol Obstet 2015;291:671-9. DOI |
14 | Laurini R, Laurin J, Marsal K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand 1994;73:529-34. DOI |
15 | Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ 2002;167:48-54. |
16 | Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 2009;102:360-70. DOI |
17 | American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin No. 196 summary: thromboembolism in pregnancy. Obstet Gynecol 2018;132:243-8. DOI |